
Quadotron 1gm/0.125mg Injection
Marketer
Neiss Labs Pvt Ltd
Salt Composition
Cefepime (1gm) + Tazobactum (0.125mg)
Overview Quadotron 1gm/0.125mg Injection
Combiflox, a dual-antibiotic injection (1g/0.125mg), combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be strictly under medical guidance. Complete the prescribed regimen, even with symptom improvement. Common reactions include nausea, vomiting, diarrhea, and skin rashes; injection site inflammation and discomfort may also occur, typically resolving spontaneously. Worsening side effects necessitate immediate medical attention. Seek immediate help for allergic reactions (rash, itching, swelling, respiratory distress). Inform your physician of all current medications before use; pregnant or lactating individuals require prior medical consultation. Alcohol consumption may enhance drowsiness. While generally driving-safe, avoid operating vehicles if experiencing somnolence or dizziness.
Uses of Quadotron 1gm/0.125mg Injection
Infections caused by bacteria
Major Benefits of Quadotron 1gm/0.125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not advised.
Common Side effects of Quadotron 1gm/0.125mg Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Quadotron 1gm/0.125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Quadotron 1gm/0.125mg Injection works:
Quadotron Injection (1g cefepime/0.125mg tazobactam) combines the antibiotic cefepime with the beta-lactamase inhibitor tazobactam. Cefepime's mechanism involves disrupting bacterial cell wall synthesis, hindering their survival. Tazobactam counteracts bacterial enzymes that would otherwise neutralize cefepime, thereby broadening cefepime's effectiveness and overcoming bacterial resistance.
SAFETY ADVICE
AlcoholCAUTION
Use of Quadotron 1gm/0.125mg Injection with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Quadotron (1gm/0.125mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; clinical data from human studies, however, remains scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Quadotron Injection (1 gm/0.125 mg) during lactation is considered safe. Research in humans indicates negligible transfer of the medication into breast milk, posing no apparent risk to the infant.
DrivingUNSAFE
Following administration of Quadotron 1gm/0.125mg Injection, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.
KidneyCAUTION
Individuals with kidney impairment should use Quadotron 1gm/0.125mg Injection cautiously. A modified dosage of Quadotron 1gm/0.125mg Injection might be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Quadotron 1gm/0.125mg Injection in patients with liver disease appears to present a low risk. Existing evidence indicates dose modification may be unnecessary, but physician consultation is advised.
What if you forget to take Quadotron 1gm/0.125mg Injection :
Should you forget a scheduled dose of Quadotron 1gm/0.125mg Injection, seek your physician's advice.
Facts to Know About Quadotron 1gm/0.125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
